NRAD - Artigos
Permanent URI for this collection
Browse
Recent Submissions
- Biópsias Percutâneas Vertebrais – Experiência do nosso CentroPublication . Gonçalves, J; Kuroedov, D; Pamplona, J; Fragata, I; Reis, JIntrodução: A biópsia percutânea vertebral tem substituído a biópsia cirúrgica aberta nos últimos 50 anos. A biópsia não-invasiva é mais custo-efetiva e tem menos complicações quando comparada com procedimentos abertos. Realizou-se uma revisão das biópsias percutâneas vertebrais realizadas no nosso centro para avaliar o yield diagnóstico e a segurança. Métodos: Analisou-se retrospetivamente 240 biópsias vertebrais percutâneas realizadas no nosso centro terciário durante 4 anos. As variáveis adquiridas incluíram técnica diagnóstica de imagem, segmento vertebral, localização da biópsia, resultados histopatológicos, tratamento adjuvante e complicações. Resultados: 102 (42,5%) dos pacientes eram mulheres, com uma média de 68 anos. A técnica mais utilizada foi a fluoroscopia (99%, n=237). A maioria dos procedimentos foi realizado no segmento lombar, representando 47% (n=112), seguido do segmento torácico (42%, n=100). Obtivemos amostra suficiente para análise histológica em 93%. Das 240 biópsias, 18 (7,5%) tiveram de ser repetidas, tendo-se obtido um diagnóstico em 14 (78%). Histologicamente, em 28% (n=67) das amostras não se obteve alterações patológicas e em 27% (n=65) confirmou-se doença metastática. Realizou-se vertebroplastia em 19% (n=46) dos casos após a biópsia. Apenas um paciente teve uma complicação clinicamente significativa secundária ao procedimento. Conclusão: A biópsia vertebral percutânea é uma importante ferramenta na avaliação de lesões vertebrais e dos tecidos paravertebrais adjacentes, e pode ser realizada com baixa morbilidade e alta taxa de deteção como um procedimento de ambulatório. Em conformidade com a literatura, a maior parte das nossas amostras eram adequadas para análise histopatológica e o achado mais comum foi lesão metastática.
- Gorham-Stout Syndrome: a Rare Cause of Osteolytic Lesions.Publication . Santos, Mariana; Conceição, Carla
- Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel OcclusionsPublication . Matsukawa, Hidetoshi; Uchida, Kazutaka; Cunningham, Conor; Sowlat, Mohammad-Mahdi; Elawady, Sameh Samir; Maier, Ilko; Jabbour, Pascal; Kim, Joon-Tae; Wolfe, Stacey Quintero; Rai, Ansaar; Starke, Robert; Psychogios, Marios-Nikos; Shaban, Amir; Arthur, Adam; Cuellar, Hugo; Howard, Brian; Alawieh, Ali; Romano, Daniele; Tanweer, Omar; Mascitelli, Justin; Fragata, Isabel; Polifka, Adam; Osbun, Joshua; Crosa, Roberto; Matouk, Charles; Park, Min; Brinjikji, Waleed; Moss, Mark; Williamson, Richard; Navia, Pedro; Kan, Peter; Leacy, Reade; Chowdhry, Shakeel; Ezzeldin, Mohamad; Spiotta, Alejandro; Levitt, Michael; Yoshimura, Shinichi; Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators; ElsevierBackground: The outcomes of endovascular thrombectomy (EVT) for medium vessel occlusions (MeVOs) of specific vascular territories remain unknown. We aimed to investigate EVT outcomes by MeVO locations using the data from an ongoing international multicenter registry. Methods: Patients with isolated MeVO who underwent EVT between January 2013 and December 2022 were retrospectively analyzed. Isolated MeVO was defined as an occlusion of the A2 or A3 (A2/A3), M2 or M3, and P2 or P3 (P2/P3). Outcomes included a 90-day modified Rankin score (mRS) of 0-2, successful recanalization (modified Thrombolysis in Cerebral Infarction score ≥ 2b), early neurological deterioration (END) or improvement (ENI), and 90-day mortality. END was defined as a worsening of ≥4 points from the baseline National Institutes of Health Stroke Scale (NIHSS) score within 24 h of EVT, while ENI was defined as an improvement of ≥4 points from the baseline NIHSS score within 24 h of EVT. Results: 1744 MeVOs included. Compared to M2 occlusions (n = 1542, 88.4%), A2/A3 (n = 36, 2.1%) occlusions had lower odds of 90-day mRS 0-2 (adjusted odds ratio [aOR] 0.30, 95% confidence interval [CI] 0.11-0.80), and P2/P3 occlusions (n = 49, 2.8%) had lower odds of successful recanalization (aOR 0.19, 95% CI 0.07-0.50), and higher odds of END (aOR 3.53, 95% CI 1.35-9.25). Other outcomes showed no significant differences. Conclusions: A2/A3 occlusions were more likely to have worse outcomes compared to M2 occlusions after EVT for patients with isolated MeVOs.
- Magnetic Resonance Diagnosis of Laryngeal Chondritis After Transoral Laser Microsurgery for Laryngeal CancerPublication . Cunha, B; Lancini, D; Rondi, P; Ravanelli, M; Maroldi, R; Paderno, A; Zigliani, G; Bertotto, I; Piazza, C; Farina, DObjective: Laryngeal chondritis (LC) is a rare complication of carbon dioxide transoral laser microsurgery (CO2 TOLMS) for laryngeal tumours and can pose a diagnostic challenge. Its magnetic resonance (MR) features have not been previously described. This study aims to characterise a cohort of patients who developed LC after CO2 TOLMS and describe its clinical and MR findings. Methods: Clinical records and MR images of all patients presenting with LC after CO2 TOLMS between 2008 and 2022 were reviewed. Results: Seven patients were analysed. Timing of LC diagnosis ranged from 1 to 8 months after CO2 TOLMS. Four patients were symptomatic. Abnormal endoscopic findings included suspected tumour recurrence in 4 patients. MR documented focal or extensive signal changes involving the thyroid lamina and para-laryngeal space with T2 hyperintensity, T1 hypointensity and intense contrast enhancement (n = 7), and minimally reduced mean apparent diffusion coefficient (ADC) values (1.0-1.5 x 10-3 mm2/s) (n = 6). A favourable clinical outcome was achieved in all patients. Conclusions: LC after CO2 TOLMS has a distinctive MR pattern. When tumour recurrence cannot be confidently excluded based on imaging, antibiotic therapy, close clinical and radiological follow-up and/or biopsy are recommended.
- Cerebral Cavernous Malformations: Typical and Atypical Imaging CharacteristicsPublication . Kuroedov, D; Cunha, B; Pamplona, J; Castillo, M; Ramalho, JCavernous malformations (CMs) are benign vascular malformations that maybe seen anywhere in the central nervous system. They are dynamic lesions, growing or shrinking over time and only rarely remaining stable. Size varies from a few millimeters to a few centimeters. CMs can be sporadic or familial, and while most of them are congenital, de novo and acquired lesions may also be seen. Etiology is still unknown. A genetic molecular mechanism has been proposed since a cerebral cavernous malformation gene loss of function was found in both familial and sporadic lesions. Additionally, recent studies suggest that formation of CMs in humans may be associated with a distinctive bacterial gut composition (microbioma). Imaging is fairly typical but may vary according to age, location, and etiology. Follow-up is not well established because CMs patients have a highly unpredictable clinical course. Angiogenic and inflammatory mechanisms have been implicated in disease activity, as well as lesional hyperpermeability and iron deposition. Imaging and serum biomarkers of these mechanisms are under current investigation. Treatment options, including surgery or radiosurgery, are not well defined and are dependent upon multiple factors, including clinical presentation, lesion location, number of hemorrhagic events, and medical comorbidities. Our purpose is to review the imaging features of CMs based on their size, location, and etiology, as well as their differential diagnosis and best imaging approach. New insights in etiology will be briefly considered. Follow-up strategies, including serum and imaging biomarkers, and treatment options will also be discussed.
- Neuroenteric Cyst: a Rare Lesion of the Spinal CordPublication . Rodrigues, M; Osório, J; Pontinha, C; Correia, M; Conceição, C
- The European Portuguese Version of the Brief Negative Symptom ScalePublication . Santos, HC; Rodrigues, A; Ferreira, S; Martins, JM; Baptista, T; Gama Marques, J; Kirkpatrick, B; Prata, DNegative symptoms reflect a currently much-untreated loss of normal functioning and are frequently found in psychotic disorders. We present the first translation of the Brief Negative Symptom Scale (BNSS) to European Portuguese and evaluate its validity in a sample of Portuguese male patients with a psychotic spectrum disorder. The Portuguese BNSS showed excellent internal consistency, high convergent validity (i.e., strong correlation with the PANSS negative factor), and high discriminant validity (i.e., a lack of association with the PANSS positive factor). In sum, the present European Portuguese BNSS has shown to be reliable, thus extending this instrument's clinical availability worldwide.
- Labyrinthine Enhancement on 3D Black Blood MR Images of the Brain As an Imaging Biomarker for Cisplatin Ototoxicity in (Lung) Cancer PatientsPublication . Veiga, M; Kuhweide, R; Demaerel, V; De Pauw, R; De Foer, B; Casselman, JPurpose: Cancer patients treated with platinum-based chemotherapy can present with ototoxicity symptoms. The purpose of this work is to report the imaging features related to cisplatin ototoxicity. Methods: Between December 2015 and March 2019, a cohort of 96 consecutive patients with lung cancer was selected. Only patients who received cisplatin chemotherapy and underwent an imaging protocol consisting of a Gd-enhanced 3D-BB and 3D-T1W sequence, as well as T2W sequence to exclude metastases, were included. Labyrinthine enhancement was assessed, and all findings regarding the auditory and vestibular function were retrieved from the clinical files. Results: Twenty-one patients met the inclusion criteria. The Gd-enhanced 3D-BB images were used to divide them into the labyrinth enhancement group (LEG) and the labyrinth non-enhancement group (LNEG). None of these patients demonstrated enhancing regions on the 3D-T1W images. The labyrinthine fluid remained high on the T2 images in all patients, excluding metastases. The LEG consisted of 6 patients. The cochlea and semicircular canals were the most frequently affected regions. All the LEG patients that presented with hearing loss (4/6) had cochlear enhancement. Patients with normal hearing had no cochlear enhancement. Five patients (5/6) showed vestibular enhancement. Four of these patients had vestibular symptoms. Conclusion: Labyrinthine enhancement as an imaging feature related to cisplatin ototoxicity is unreported. This study demonstrates a correlation between hearing loss and cochlear enhancement and also between vestibular impairment and vestibular/semicircular enhancement on 3D-BB images, which remained invisible on the 3D-T1W images. The labyrinthine enhancement on 3D-BB images in the presence of normal signal intensity of the intralabyrinthine fluid can be used as an imaging biomarker for cisplatin toxicity in daily clinical practice and should not be mistaken for intralabyrinthine metastases.
- Neuroimaging Findings in Paediatric Patients with Sickle Cell DiseasePublication . Abreu, VS; Xavier, S; Santos, M; Lopes da Silva, R; Kjöllerström, P; Conceição, CSickle cell disease (SCD) is an autosomal recessive haemoglobinopathy, which manifests as multisystem ischaemia and infarction, as well as haemolytic anaemia. The morphological changes of red blood cells (RBCs) that promote ischaemia/infarction as the main multi-systemic manifestation, with associated vasculopathy, may also lead to haemorrhage and fat embolisation. Bone infarctions, whether of the skull or spine, are relatively common with subsequent increased infectious susceptibility. We present a broad spectrum of brain and spine imaging findings of SCD from a level III paediatric hospital in Lisbon, between 2010 and 2022. Our aim is to highlight brain and spine imaging findings from a serial review of multiple patients with SCD and respective neuroimaging characterisation.
- Subpial Hemorrhage : A Distinctive Neonatal Stroke PatternPublication . Pinto, C; Cunha, B; Pinto, MM; Conceição, CBackground and purpose: Subpial hemorrhage is a rare form of neonatal stroke, still poorly understood. The aim of this study was to characterize a cohort of term and preterm neonates with subpial hemorrhages and contribute to a better knowledge of this condition. Material and methods: Clinical records and magnetic resonance (MR) imaging data of all neonates with subpial hemorrhage followed at a pediatric hospital between 2010 and 2020 were retrospectively reviewed. Results: A total of 10 patients were included in the analysis, 40% of whom were term neonates. Operative vaginal delivery was registered in 30%. Temporal was the most common location of subpial hemorrhage (70%), and all patients displayed underlying brain infarction. A characteristic yin-yang pattern was present in 90% of the study cohort, and ingurgitation of medullary veins on susceptibility weighted imaging in 80%. Cerebellar microbleeds were observed in 60% of neonates, both term and preterm. When available, MR angiography and venography were unremarkable. Patients' clinical outcome was variable, with early prematurity not associated to worse outcomes. Conclusion: Subpial hemorrhage has a distinctive MR pattern, with underlying parenchymal venous infarction, and can occur in term and preterm neonates. This study results suggest an association between subpial hemorrhage and cerebellar microbleeds but further studies are required to confirm it and better understand the pathophysiology of subpial hemorrhage.